Confidential opportunity to acquire an established, multi-location regenerative and wellness healthcare platform operating across four Hawaii clinic locations.

The business generated approximately $4.60 million in 2025 revenue and $1.47 million in normalized EBITDA, representing an approximately 31.8% normalized EBITDA margin.

The company operates clinics on Oahu, Maui and Hawaii Island, providing elective, primarily self-pay services focused on musculoskeletal, neurological, regenerative and wellness care. Offerings include joint and nerve treatment programs, PRP, A2M, BMAC, peptide therapy and selected hair and skin restoration services.

A major strength of the opportunity is the existing operating infrastructure. Day-to-day operations are overseen locally by an experienced Clinic Director working approximately full-time, supported by licensed providers, medical assistants, front-office personnel and dedicated marketing staff. The majority owner is largely removed from routine daily operations.

The business has demonstrated substantial growth, with revenue increasing from approximately $2.02 million in 2023 to $4.12 million in 2024 and $4.60 million in 2025.

The company also benefits from an established patient-acquisition platform utilizing social media, webinars, radio, television, seminars, events and referral relationships. Management has identified additional opportunities through expanded service offerings, increased utilization of existing clinics and providers, continued development of referral channels and potential geographic expansion.

The contemplated transaction includes the Hawaii operating platform, furniture, fixtures, medical and office equipment, inventory, and transferable business, brand and digital assets, subject to final transaction terms.

Qualified buyers will be required to execute a confidentiality agreement and complete an investor profile demonstrating sufficient financial capacity before the business identity and confidential information are released.